CNBC Stock Blog
- 3 Safe Investments That Let You ‘Sleep Better:’ Strategist
- Beware of 'Trampling Effect' When Market Tops: Manager
- Gold Heading to $1150: Art Hogan
- More Upside if S&P Passes This Number: Market Pro
- Playing Activision and Other Video Game Stocks: Analyst
- Expect 'At Least' Another 10-15% Upside: Fund Manager
- Why are Options Bullish on This Smartphone Maker?
- Why are Traders Bullish on This Food Company?
- Profiting From Natural Gas: Strategists
- 3 Hot Mid-Cap Stock Picks: Portfolio Manager
MOST SHARED
- JPMorgan Chase to Hire 1,200 Mortgage Officers
- Bear Stearn Fund Managers Not Guilty on All Counts
- Oil Tomorrow
- Parsing Treasury's Loan Modification Report
- Adobe Cuts 680 Jobs, to Take Charge
- Gold Heading to $1150: Art Hogan
- Zucker to Head New NBCU-Comcast Venture: Sources
- Toll Brothers: More Contracts Signed, but Sales Down
- Fed's Lacker: US in a 'Good Place' With Inflation
- Beware of 'Trampling Effect' When Market Tops: Manager
- Gold Heading to $1150: Art Hogan
- Starbucks Brews Up Growth
- Farr: An Extended Period—No Fat Lady in Sight
- More Upside if S&P Passes This Number: Market Pro
- Murdoch Lashes Out At Google
- Fighting The Flu Vaccine Critics
- Nov. 10: Unusual Volume Leaders
- Shadow Inventory Dwarfs Loan Mods
- Apple Surpasses Nokia as Top Handset Maker by Profit
- Three Things the US Can Do To Stop the Dollar's Decline
- Toll Brothers: More Contracts Signed, but Sales Down
- Fed's Lacker: US in a 'Good Place' With Inflation
- Bear Stearn Fund Managers Not Guilty on All Counts
- Commodity ETFs: Returns May Not Match Expectations
- JPMorgan Chase to Hire 1,200 Mortgage Officers
- Ponzi Proceeds: Bidding on Madoff's Toys
- Quiz: Do You Know Your Coca-Cola Myths?
RSS FEED
Text Size 
writer, OptionMonster
Shares of Human Genome Sciences are up on the day Thursday and bringing in option traders.
HGSI stock [HGSI
Loading...
()
] is up more than 4 percent to $3.15 in early afternoon trading, well off the $3.44 high of the day that was reached just after the open. The shares have been strongly bullish since the low of just $0.45 back in March, putting the stock up more than 600 percent.
Today's options action focuses on the October expiration, where we see 4,100 of the October 5 calls purchased, the largest block for $0.80. OptionMonster's systems also show some of the October 2.50 calls sold, with one block of 1,000 going for $1.40, which will help offset the cost of the other calls bought by the same trader.
Options Trading School:
This is a clearly a longer-term bet that HGSI will climb back to levels seen last October, when the stock dropped from levels above $7 to below $2.50 in a month.
___________________________
Other Biopharma/Biotech Firms:
Amgen [AMGN
Loading...
()
]
Biogen Idec [BIIB
Loading...
()
]
Genzyme [GENZ
Loading...
()
]
Gilead Sciences [GILD
Loading...
()
]
___________________________
___________________________
Chris McKhann is an analyst and writer for OptionMonster.
___________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes